Product Information
CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.9753 per EA under NDC 33342013115. Its NADAC has been published 523 times since Aug 17, 2016.
FDA first approved this application on Feb 27, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB
Candesartan Cilexetil and HydrochlorothiazideStrength
16; 12.5 mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342013115
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204100FDA Approved
2/27/2015
TE Code
AB
On Market Since
3/7/2015
Pharmacological Classes
Price Statistics
The NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB has been published 523 times since Aug 17, 2016, and over the history we have for it it has declined 69.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9753 per EA |
|---|---|
| All-time high | $3.6028 (Mar 15, 2017) |
| All-time low | $0.6502 (Nov 20, 2024) |
| 52-week high | $1.0596 |
| 52-week low | $0.7758 |
| Median price | $1.9356 |
| Average price | $2.0144 |
| Largest weekly change | +54.4% (Sep 18, 2024) |
| Weeks tracked | 523 |
| Tracking since | Aug 17, 2016 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB, manufactured by Macleods Pharmaceuticals Limited, is $0.9753 per EA (NDC 33342013115), effective Aug 19, 2026.
How has the price of CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB changed over time?
Over the history we have for it, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB has declined 69.9%. It has been tracked across 523 weekly CMS publications since Aug 17, 2016.
What are the highest and lowest recorded NADAC prices for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?
Since Aug 17, 2016, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB has ranged from a low of $0.6502 (Nov 20, 2024) to a high of $3.6028 (Mar 15, 2017), with a median of $1.9356 per EA.
Are there cheaper alternatives to CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?
CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB (NDC 33342013115) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.